Le Lézard
Classified in: Health
Subjects: AWD, SCZ

Chelsea at Brookfield Assisted Living Earns 2019 AHCA/NCAL Bronze National Quality Award

BELVIDERE, N.J., June 5, 2019 /PRNewswire/ -- The Chelsea at Brookfield, 1 Brookfield Court, Belvidere, New Jersey, has been recognized as a 2019 recipient of the Bronze Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL) for its commitment to improving the lives of residents through quality care. The distinction is the first of three progressive award levels through the AHCA/NCAL National Quality Award Program. The program, presented by the leading association in long-term and post-acute care, honors association members across the country that have demonstrated their dedication to improving the quality of care for seniors and persons with disabilities.

"I am so proud of our staff for the hard work that made this award possible," remarked Stephanie Ponist, Executive Director of The Chelsea at Brookfield. "We strive to provide an outstanding living environment and care to our residents. To see that work acknowledged in this way is truly rewarding."

The Bronze Award acknowledges essential performance elements such as vision, mission statement, and key strengths and challenges. Bronze applicants must also demonstrate their ability to implement a performance improvement system. Trained examiners review each Bronze application to determine if it has met the demands of the criteria. The Bronze Award is the first of a three-tiered program that continues to develop quality improvement over time.

"I applaud The Chelsea for taking this important step towards quality improvement," said the AHCA/NCAL National Quality Award Board of Overseers Chair, Alana Wolfe. "I encourage The Chelsea to continue on its path to achieving the highest of quality care."

The awards will be presented during AHCA/NCAL's 70th Convention & Expo in Orlando, Florida, October 13-16, 2019.

Media contact:
Tom Kranz

Related Images

Christine with reading resident
Staffer Christine Keenan with resident

SOURCE Chelsea Senior Living

These press releases may also interest you

at 07:05
Updated results from the PACIFIC Phase III trial showed AstraZeneca's IMFINZI® (durvalumab) demonstrated a sustained, clinically meaningful overall survival (OS) and progression-free survival (PFS) benefit in patients with unresectable, Stage III...

at 07:05
Deciphera Pharmaceuticals, Inc. , today announced the presentation of nine month follow-up data from the Company's Phase 3 INVICTUS study of QINLOCK in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors (GIST) and...

at 07:05
AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that LYNPARZA demonstrated a long-term progression-free survival (PFS) benefit versus placebo as a 1st-line maintenance treatment in patients with...

at 07:05
Spectrum Pharmaceuticals , a biopharmaceutical company focused on novel and targeted oncology therapies, today presented additional results from its pivotal Phase 2 clinical trial, ZENITH20, evaluating poziotinib in previously treated non-small cell...

at 07:05
Trillium Therapeutics Inc. ("Trillium" or the "Company") , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointment of pharmaceutical industry leader Michael Kamarck, Ph.D.,...

at 07:03
In observance of Childhood Cancer Awareness Month, the third week of September is going to the dogs in the best way possible, in support of the lifesaving mission of St. Jude Children's Research Hospital®: Finding cures. Saving children.® ...

News published on 5 june 2019 at 13:21 and distributed by: